Marc Davies leaves PwC to become Flexicare Finance Director
Marc Davies has been appointed as a Finance Director for medical device manufacturers Flexicare. Davies brings 15 years of experience to the role, having latterly been a Director in Corporate Finance at Big Four accountancy and consultancy PwC.
Flexicare is a leading UK manufacturer of medical devices, distributing to over 100 countries worldwide through a network of distributors and subsidiaries. The group, based in Mountain Ash, draws on a legacy of 35 years in design and development, while being encouraged to innovate by a modern manufacturing facility.
The company has offices across Europe, the Middle East, India, Far East, USA and Australia, in order to respond to customers’ needs, providing a fast and efficient service in an industry where insurance premiums continue to skyrocket.
Former PwC employee Marc Davies has been confirmed as a new Finance Director for the medical manufacturers. An Oxford graduate, Davies holds an MSc (Distinction) in Mathematics, and first arrived at PwC after finishing his post-graduate studies in 2002. Davies initially worked in the Big Four firm’s Corporate Recovery department, until June 2007.
Davies would return to the company six years later, working his way to Director of Corporate Finance before his exit this month. In between his stints with the world’s largest consulting firm, Davies, who is also an ICAEW Chartered Accountant, spent almost two years in corporate finance with Rowan Dartington, and a further four years with WHIreland Corporate & Institutional Broking’s own corporate finance department.
This appointment is not the first example of consulting and health industries crossing over, meanwhile. There has been movement in both directions, with consulting firms keen to involve themselves in a billion dollar industry, and healthcare industry incumbents looking to diversify and offer new services. The healthcare industry has increasingly seen companies move into consulting over the past few months, including UDG Healthcare’s $22 million deal for US management consultancy Vynamic. Meanwhile, consulting group Atos purchased three firms in the US healthcare IT advisory market.
